RTK/GPCR Flashcards
what do receptor tyrosine kinases control
the rate of cell proliferation and growth
what do insulin receptors regulate
glucose homeostasis
which ligands for RTKs are dimers
PDGF - platelet derived
NGF - nerve
VEGF - vascular endothelial
which ligands for RTKS are monomers and what do they cause
EGF - epidermal
cause conformational rearrangement of the receptor and dimerization
what is receptor dimerization
when two receptor subunits come close to each other
their intracellular domains (tyrosine resideues) cross phosphorylate each other
What does the SH2 domain recognize
P-Tyr and 3 AAs on the C terminal side
PTB domain recognizes
the N terminal side of P-Tyr
SH3 domain recognizes
proline rich sequences
PH domain recognizes
lipids: PI bi and triphosphates
=phosphatidylinositol bi and tri’s (PI3, 4P2, & PI3,4,5P3
etc)
RAS is a
low molecular weight GTPase
slow GTPase so it’s inefficient
what does GTPase Activating protein do
it’s a protein cofactor known as GAP that binds to RAS
turns RAS-GTP into RAS GDP and Pi by increasing efficiency of GTP hydrolysis
what does GDP/GTP exchange factor (GEF) do
changes bound GDP to RAS into the active form Ras-GTP so that GTP can be disassociated from RAS
what are the hydrophobic anchors of RAS that attach it to the plasma membrane so that it can participate in signal transaction
farnesyl residue
Fatty Acid
what are the domains of GRB2
which is used to bind to active RTK
which domain is used to bind to SOS
SH3-SH2-SH3
SH2 binds it to RTK
SH3 binds to SOS
RAS is a significant protein in what
cancer with 40% of solid tumors containing a mutation in RAS
what does activation of the MAP kinase pathway control
cell proliferation
in the cytosol, ERK controls translation by doing what
phosphorylating and inhibiting TSC2
TSC2 is a protein that binds to TSC 1
what do mutations in TSC1 and TSC2 lead to
lymphangioleiomyomatosis and tuberous sclerosis complex
-benign tumors in brain, heart, kidneys, skin
TSC2 is a
GTPase activating protein for Rheb (Ras homolog enriched in brain)
Rheb/GTP activates ____
mTORC1
mTORC1 increases
cell growth by stimulating protein synthesis at the level of translation
TSC1/2 complex acts as a ____ and converts ___
GAP for Rheb and converts Rheb-GTP to Rheb-GDP inactivating it
how do mutations in TSC1/2 cause tuberous sclerosis complex
the TSC1/2 complex is not phosphorylated and inhibited
so the Rheb-GTP is NOT converted to Rheb-GDP (inactive)
so Rheb is in active form Rheb-GTP which activates mTORC1
which increase rate of protein syntheis –> incr size of cell (cell growth) –> cell division rate is same –> tumor formation
what is tuberous sclerosis complex and what’s it caused by
autosomal-dominant multisystem disordor
casuses formation of benign tumors all over body
underlying genetic cause: mutation in TSC1 or TSC2 gene
–> overactivation of rapamycin complex (mTORC)
how to treat Tuberous sclerosis complex
mTOR inhibition such as monoclonal antibody Everolimus
mTOR is aka ___ which is used in the clinic as ___
rapamycin complex which is used as an antiproliferative drug in treating TSC and certain cancers
ways to terminate MAPK pathway
hint: 4 ways
spontaneous hydrolysis of GTP to GDP –> inactivates Ras
Ras-GAP (turns Ras-GTP to Ras-GDP) –>inactivates Ras
protein phosphatases (dephosphorylate and deactivate every component of the signaling pathway)
internalization of the receptor (decr concentration of activated receptor to plasma membrane inhibits the signaling)
T/F:
under basal conditions, PI3K type 1A is active
FALSE
it’s inactive during basal conditions
what are the regulatory and catalytic subunits needed for PI3K path
Regulatory subunit p85 (bound to SH2 domain on receptor to allow p110 to be active)
catalytic subunit p110 (bound to Ras-GTP)
activation of PI3K increase the concentration of what, where
incr conc of PIP3 in plasma membrane
how are PDK1 and AKT recruited to the membrane
via their PH domains
how to terminate the PI3K path
protein and lipid (PTEN) phosphatases dephosphorylate PIP3 to make PIP2 –> inhibits AKT path
what happens to AKT when under basal conditions
AKT not active
PH domain binds to it’s Kinase domain –> inhibits activity